About
Robert A. Michael is AbbVie's Chairman of the Board and Chief Executive Officer, a role he has held since July 2025; he became CEO in 2024 and served as President and Chief Operating Officer from July 2023 to June 2024. He previously held a series of senior finance leadership roles at AbbVie, including Vice Chairman and President, Vice Chairman, Finance and Commercial Operations and Chief Financial Officer, and Executive Vice President, Chief Financial Officer. Mr. Michael first joined Abbott in 1993 and held numerous leadership positions across several business units before joining AbbVie in 2013. He has served as an AbbVie director since 2024.
Roles
AbbVie Inc.
Chairman of the Board and Chief Executive Officer · Current role
2024–present
AbbVie
Chief Executive Officer
2024 - 2025
AbbVie
President and Chief Operating Officer
Jul 2023 - Jun 2024
AbbVie
Vice Chairman and President
Jun 2022 - Jul 2023
AbbVie
Vice Chairman, Finance and Commercial Operations and Chief Financial Officer
Jun 2021 - Jun 2022
AbbVie
Executive Vice President, Chief Financial Officer
2019 - 2021
Abbott
Various leadership positions · Joined Abbott in 1993; joined AbbVie in 2013
1993 - 2013
Fixed Compensation
FY 2025
Change in Pension Value & Nonqualified Deferred Compensation Earnings
$8,647,081
All Other Compensation
$516,293
Performance Compensation
Data from FY 2025
Cash incentive
Annual Cash Incentive (Non-Equity Incentive Plan Compensation)
$5,200,000
Target Opportunity
165% of base salary
Stock awards
Stock Awards (grant-date fair value)
$13,268,456
Option Awards (grant-date fair value)
$3,199,154